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1 and C-3 substituted indole shiff bases to understand the structural features that inﬂuence the
inhibitory activity toward the cyclooxygenase-2 (COX-2) enzyme. The calculated QSAR results
revealed that the drug activity could be modeled by using molecular connectivity indices (0v, 1v,
2v), wiener index (W) and mean wiener index (WA) parameters. The predictive ability of models
was cross validated by evaluating the low residual activity, appreciable cross validated r2 values
(R2cv) and leave one out (LOO) technique.
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The non-steroidal anti-inﬂammatory drugs (NSAIDs) like
aspirin are among the most common medications in the world
(Vane, 1971). The mechanism of action of these drugs is the
inhibition of the cyclooxygenase (COX) enzyme, which cata-
lyzes the ﬁrst step of the biosynthesis of PGG2 from arachi-
donic acid to generate prostaglandin H2 (Hamberg and
Samuelsson, 1973). The next hierarchical step in enzyme catal-
ysis is to convert prostaglandin H2 to other prostaglandins andthromboxanes and ﬁnally bind to G-protein-coupled receptors
and effect diverse biological responses (Funk, 2001).
On the basis of crystal structures, the two isoforms (COX-1
and COX-2) have been identiﬁed. Cyclooxygenase-1 (COX-1)
which is mainly associated with prostaglandin production in
gastric mucosa and thromboxane production in platelets
(Smith et al., 2000) and COX-2 whose expression is upregu-
lated in response to inﬂammatory stimuli and elevates prosta-
glandin levels as part of the inﬂammatory response.
Identiﬁcation of this alternate role of COX-2 has led to devel-
opment of the COX-2 selective NSAIDs such as rofecoxib,
celecoxib, and valdecoxib. These drugs have good anti-inﬂam-
matory activity, but with reduced ulcerogenicity compared to
nonselective NSAIDs. Despite their commercial success, cur-
rent COX-2 selective inhibitors may still exhibit undesirable
side effects, including the increased risk of adverse thrombo-
embolytic events in susceptible individuals (Solomon et al.,
2002; FitzGerald, 2004). Enzyme speciﬁcity is also an issue,
as the sulfonamide containing inhibitors celecoxib and valdec-
oxib can also inhibit carbonic anhydrase II (Klebe et al., 2004).
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was shown recently that COX-1 is over expressed in some
ovarian cancer cells, where it stimulates angiogenesis (Gupta
et al., 2003). Thus, a more detailed understanding of COX iso-
form differences could aid in the design of more selective, and
potent, inhibitors of both COX isoforms. Both COX-1 and
COX-2 are isomorphs however, the selectivity of COX-2 over
COX-1 is due to the central channel of COX-2 which is larger
(17%) than that of COX-1. This difference in size is due to
the change of some amino acid residues that increase the size
and change the chemical environment of the binding pocket
of NSAIDs. The most critical structural feature conferring sen-
sitivity to inhibition by COX-2 is the exchange of valine in
COX-2 at positions 434 and 523 in place of isoleucine in
COX-1. (It is important to note that the residues in COX-2
are given the same number as their equivalent amino acids in
COX-1 for convenience; however, the exact amino acid residue
number in COX-2 should be calculated by subtracting 14 from
the COX-1 number) (Luong et al., 1996; Iyashiro and Penning
et al., 1996; Copeland et al., 1994). Also in COX-2, 17th amino
acids are absent from the N terminus and 18th amino acids are
inserted at the C terminus in comparison to COX-1. (Otto and
Smith, 1995; Herschman, 1996).
The COX-2 enzyme is the inducible isoform that is pro-
duced by various cell types
upon exposure to cytokines, mitogens, and endotoxins re-
leased during injury and therefore molecules that inhibit its
enzymatic activity would be of therapeutic value (Smith and
Dewitt, 1996) The gastrointestinal side effects associated with
NSAIDs are due to the inhibition of gastroprotective PGs syn-
thesized through the COX-1 pathway. Thus, selective inhibi-
tion of COX-2 over COX-1 is considered to be highly useful
for the treatment of inﬂammation and inﬂammation associated
disorders with reduced gastrointestinal toxicities when com-
pared with NSAIDs (Meade et al., 1993).
The present work aims to develop the understanding to-
ward the inhibition of COX-2 with the help of QSAR. For this
purpose we have taken the activity data (IC50) that were re-
ported by Kaur et al. (2012). The physicochemical properties
of a drug play a major role in the development of formulation
and bioavailability and thus we have taken some physicochem-
ical parameters like molecular connectivity indices (0v, 1v, 2v)
with wiener index (W) as, mean wiener index (WA), and molec-
ular weight (MW) for the present article.
2. Experimental section
2.1. Methodology
Inhibitory activity as reported by Kaur et al. (2012) as IC50
were converted into their log units (log IC50) and used in the
present investigation. An attempt has been made to correlate
the activity of these compounds with various physicochemical
parameters such as surface tension (st) (Hansch and Fujita,
1964), wiener index (W), mean wiener index (WA), molecular
weight (MW) (Hansch and Fujita, 1964) and molecular con-
nectivity (0v, 1v, 2v) and have been used to study the relation-
ship between parameters and properties. St and mw were
calculated by ACD Lab Chem. Sketch Software version 12
(ACD/ChemSketch 10 (2006); www.acdlabs.com) whereas
W, WA,
0v, 1v, 2v were evaluated by E-Dragon Software(www.vcclab.org/). The multiple regressions used to derive
the correlation were executed with the SPSS 7.5 version
program.
2.2. Parameters used
2.2.1. Molecular connectivity index
The ﬁrst order connectivity index v(G) of a graph G is deﬁned
by Randic (1975) as follows:
v ¼ vðGÞ ¼
X
jk
½djdk0:5
where dj and dk are the valences of vertices j and k that are
equal to the number of bonds connected to the atoms j and
k, in G. In the case of hetero-systems the connectivity is given
in terms of valence delta values dj and dk of atoms j and k and
is denoted by vr. This version of the connectivity index is called
the valence connectivity index and is deﬁned as follows:
Xr ¼ vrðGÞ ¼
X
jk
½drjdrk0:5
where, the sum of all bonds j and k of the molecule is taken.
Valence delta values are given by the following expression:
Dvj ¼
Zvj Hj
Zj  Zk  1
where Zj is the atomic number of atom j, Z
v
j is the number of
valence electrons of the atom j and Hj is the number of hydro-
gen atoms attached to atom j. The Dvj values are available in
the book written by Kier and Hall (1976).
2.2.2. Indicator parameters
Indicator variables or parameters, sometimes called dummy
variables or de novo constants (Recantint et al., 1986) are used
in linear multiple regression analysis to account for certain fea-
tures which cannot be described by continuous variables. In
QSAR equations, they normally describe a certain structural
element, be it a substituent or another molecular fragment.
Thus, Free Wilson analysis may be interpreted as a regression
analysis approach using only indicator variables.
2.2.3. Molecular weight (MW)
Molecular weight descriptor has been used as the descriptor in
systems such as transport studies where diffusion is the mode
of operation. It is an important variable in QSAR studies per-
taining to cross-resistance of various drugs in multi-drug resis-
tant cell lines
2.2.4. Wiener index (W)
Wiener index (W) is a widely and oldest used topological in-
dex. It is based on the vertex-distances of the respective molec-
ular graph. The Wiener index (W) was proposed in 1947 by
Wiener and it is deﬁned as the sum of overall bonds of the
product of the number of vertices on each side of the bond.
Let us denote a molecular graph G and v1, v2, v3,. . .,vn its ver-
tices. Let d(vj; vk/G) stand for the distance between the vertices
vij and vk. Then the Wiener (1947) index is deﬁned as:
W ¼WðGÞ ¼ 1=2
Xn
j
Xn
k
dðvj; vkjGÞ
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The 2D structures of the molecules were drawn using Chem
Sketch software. Several physicochemical parameters were cal-
culated for the present series (Kaur et al., 2012) such as wiener
index (W), mean wiener index (WA), molecular connectivity
(0v)5, (1v)5, (2v)5 and molecular weight (MW), which have been
found to be useful in QSAR based drug modeling (Srivastava
et al., 2008a, b, c; Agarwal et al., 2003, 2005, 2006; Khadikar
et al., 2002, 2003a, b, 2005a, b). Except molecular weight
(MW) all physicochemical parameters were calculated with
E-Dragon software, molecular weight was calculated by
ACD Lab Chem Sketch software. The indicator parameter
has also been used which accounts for the Fluorine (F) group
at R2 position. Regression analysis was performed by using
SPSS 7.5 version. It is important to note that the indicator
parameter should not be orthogonal in the matrix correlation
(Table 2) and its value must be less than 0.50.
All the compounds of the series along with, calculated
physicochemical parameters are given in Table 1. In multiple
regression analysis, the independent variables must be orthog-
onal and consequently the autocorrelation among the descrip-
tors was checked and is given in the correlation matrix in
Table 2. Statistically signiﬁcant models were obtained when
one of the parameters (W), (WA), (
0v), (1v), (2v), (MW), is com-
bined with the indicator parameter. The models obtained are
reported as:
pIC50 ¼ 0:876ð0:608ÞIþ 0:374ð0:161Þ2vþ 1:173 ð1Þ
n= 10, R= 0.910, R2 = 0.829, R2A ¼ 0:780, S.E. = 0.359,
F(2,7) = 16.935, Q= 2.535
pIC50 ¼ 0:833ð0:616ÞIþ 0:001ð0:001ÞWþ 3:431 ð2Þ
n= 10, R= 0.906, R2 = 0.821, R2A ¼ 0:770, S.E. = 0.366,
F(2,7) = 16.089, Q= 2.475Table 1 Biological activity and physicochemical data of substituted
N
N
R1
Sl. no. R1 R2 W WA
0v
1 H F 664 4.34 12.3
2 H CH3 664 4.34 12.3
3 H CF3 1045 4.976 14.8
4 CH2Ph F 1613 5.377 17.0
5 CH2Ph CH3 1613 5.377 17.0
6 CH2Ph CF3 2270 6.005 19.5
7 COPh F 1744 5.366 17.9
8 COPh CH3 1744 5.366 17.9
9 COPh CF3 2437 6.002 20.4
10 COPh Cl 1744 5.366 17.9pIC50 ¼ 0:870ð0:623ÞIþ 1:181ð0:526ÞWA  1:074 ð3Þ
n= 10, R= 0.906, R2 = 0.820, R2A ¼ 0:769, S.E. = 0.367,
F(2,7) = 15.960, Q= 2.469
pIC50 ¼ 0:822ð0:669ÞIþ 0:239ð0:118Þ0vþ 1:169 ð4Þ
n= 10, R= 0.888, R2 = 0.789, R2A ¼ 0:728, S.E. = 0.398,
F(2,7) = 13.064, Q= 2.231
pIC50 ¼ 0:829ð0:678ÞIþ 0:012ð0:006ÞMWþ 1:249 ð5Þ
n= 10, R= 0.885, R2 = 0.784, R2A ¼ 0:722, S.E. = 0.402,
F(2,7) = 12.706, Q= 2.201
pIC50 ¼ 0:730ð0:773ÞIþ 0:327ð0:201Þ1vþ 1:342 ð6Þ
n= 10, R= 0.843, R2 = 0.711, R2A ¼ 0:628, S.E. = 0.466,
F(2,7) = 8.609, Q= 1.809In the calculated model Eqs (1)–(6),
we have used as the symbol n for the number of compounds
in the data set, R for the correlation coefﬁcient, R2 for the coef-
ﬁcient of determination, R2A for the adjusted R
2, SE for the
standard error of estimate, F for the variance ratio (Diudea,
2000; Bikash et al., 2003) and Q for the quality of ﬁt (Pogliani,
1994; Pogliani, 1996). The positive sign of coefﬁcients of indi-
cator parameter shows that the F group has a positive inﬂu-
ence on activity and should be retained at R2 position in the
future drug designing. The above equations show that the coef-
ﬁcient of different orders of molecular connectivity parameters
(0v, 1v, 2v), mw, WA and W are positive and this indicates that
bulkier substituents with more branching should be preferred
for future modeling. The high values of R, R2 and low values
of S.E. indicate the statistical signiﬁcance of the proposed men-
tioned models.
On the basis of calculated statistical parameter it is evident
that model 1 is the best among all bi-parametric models dis-
cussed above. The quality factor Q is the ratio of correlation
coefﬁcient to its standard error of estimation i.e. Q= R/S.E.
thus higher the value of R, the lower the S.E., the greater willindole Schiff bases.
R2
1v 2v MW I pIC50
72 8.826 7.749 238.260 1 4.764
72 8.826 7.749 234.296 0 4.517
72 10.038 9.707 288.267 0 4.936
62 12.293 10.811 328.382 1 6.149
62 12.293 10.811 324.418 0 4.757
62 13.504 12.769 378.390 0 6.076
33 12.720 11.232 342.366 1 6.367
33 12.720 11.232 338.402 0 4.906
33 13.932 13.190 392.373 0 6.495
33 12.720 11.232 358.820 0 5.185
Table 2 Correlation matrix demonstrating physicochemical parameters with indicator parameters.
pIC50 W WA
0v 1v 2v MW I
pIC50 1.000
W 0.749 1.000
WA 0.735 0.985 1.000
0v 0.731 0.992 0.983 1.000
1v 0.711 0.980 0.963 0.990 1.000
2v 0.738 0.992 0.994 0.995 0.974 1.000
MW 0.725 0.985 0.977 0.995 0.983 0.990 1.000
I 0.311 0.245 0.270 0.243 0.188 0.272 0.249 1.000
Table 3 Comparison between observed and predicted activ-
ities and their residual values for equation 3.
pIC50 Predicted Residual
1. 4.764 4.94471 .18071
2. 4.517 4.06908 .44792
3. 4.936 4.80079 .13521
4. 6.149 6.08898 .06002
5. 4.757 5.21335 .45635
6. 6.076 5.94505 .13095
7. 6.367 6.24631 .12069
8. 4.906 5.37068 .46468
9. 6.495 6.10238 .39262
10. 5.185 5.37068 .18568
y = 0.8287x + 0.9275
R2 = 0.8287
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Figure 1 A plot showing comparison between observed and
predicted activity values using equation (1).
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Q parameter for the model expressed by Eq. (1) [Q = 2.535]
conﬁrms that this model has excellent statistics as well as excel-
lent predictive power. It is to note that the activity and indica-Table 4 Predictive error of coefﬁcient of correlation (PE) and cros
Sl. no. Model n R 1R2 PE 6
1. 1. 10 0.910 0.171 0.036 0
2. 2. 10 0.906 0.179 0.038 0
3. 3. 10 0.906 0.180 0.038 0
4. 4. 10 0.888 0.211 0.044 0
5. 5. 10 0.885 0.216 0.046 0
6. 6. 10 0.843 0.289 0.061 0
PRESS =
P
(Xobs – Xcal)
2; SSY =
P
(Xobs – Xmean)
2; PSE =
p
PRESS/tor parameters show best correlation with 2v, followed by W
and WA descriptors (Table 2). The remaining descriptors are
not correlated up to the mark with activity and indicator
parameters that reﬂect in the model equations (Eqs. (4)–(6)).
Predicted and residual activity values for model no. 1 are
given in Table 3. Predicted values are the calculated activities
obtained from model no. 1 and the residual values are the dif-
ference between the observed biological activities and calcu-
lated activities. The plot of observed pIC50 verses predicted
pIC50 for Eq. (1) is shown in graph (Fig. 1) and the predicted
R2 was found to be fairly large.
4. Cross validation
The cross validation analysis was performed using leave one
out (LOO) method (Cramer et al., 1988) in which one com-
pound is removed from the data set and the activity is corre-
lated using the rest of the data set. The cross-validated R2
was found to be very close to the value of R2 for the entire data
set and hence these models can be termed as statistically
signiﬁcant.
Cross validation provides the values of PRESS, SSY and
R2cv and PSE from which we can test the predictive power of
the proposed model. The meanings of these cross- validated
parameters are given as a footnote to the Table 4. It is argued
that PRESS, is a good estimate of the real predictive error of
the model and if it is smaller than SSY the model predicts bet-
ter than chance and can be considered statistically signiﬁcant.
Furthermore, the ratio of PRESS/SSY can be used to calculate
approximate conﬁdence intervals of prediction of a new com-
pound. To be a reasonable QSAR model PRESS/SSY should
be smaller than 0.4 and for our best models the value of this
ratio is 0.207. The calculated result revealed that this model
is excellent. Also, if PRESS value is transformed into a dimen-
sionless term by relating it to the initial sum of squares, we ob-
tain R2cv i.e. the complement to the traces of unexplaineds-validation parameters for the proposed models.
PE PRESS SSY PRESS/SSY R2cv PSE
.216 .900 4.353 0.207 0.793 0.300
.222 .939 4.314 0.218 0.782 0.148
.228 .945 4.308 0.219 0.781 0.307
.264 1.110 4.143 0.268 0.732 0.333
.276 1.135 4.118 0.276 0.724 0.337
.366 1.518 3.735 0.406 0.594 0.390
n.
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good properties. However, for practical purposes of end users
the use of square root of PRESS/n, which is called predictive
square error (PSE), is more directly related to the uncertainty
of the predictions. The PSE values also support our results.
The calculated cross-validated parameters conﬁrm the validity
of the models (Diudea, 2000; Bikash et al., 2003).
5. Predictive error of coefﬁcient of correlation (PE)
The predictive error of coefﬁcient of correlation (PE) (Chatter-
jee et al., 2000) is yet another parameter used to decide the pre-
dictive power of the proposed models. This parameter is
calculated by using the following expression:
PE ¼ 2
3
1 R2
3
ﬃﬃﬃ
n
p
where R2 is the coefﬁcient of determination and N is the
number of compounds used in the proposed model. We have
calculated the PE value of all the proposed models and they
are reported in Table 4. It is argued that if
(i) R< PE, then correlation is not signiﬁcant;
(ii) R> PE, several times (at least three times), then corre-
lation seems to be good; and if
(iii) R> 6PE, then the correlation is deﬁnitely good.
(iv) For all the models developed the condition R> 6PE
and hence they can be said to have good predictive
power.
6. Conclusion
In this work, we have reported the QSAR calculated values
that are based on regression analysis using experimental
PIC50 values. Calculated result revealed that, for future drug
designing in this series, the more bulkier substituents having
more branching should be preferred. The positive sign of coef-
ﬁcient of indicator parameter (I) clearly indicates that ﬂuorine
at R2 position should be retained as it is beneﬁcial toward the
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